Moderna says its low-dose pediatric vaccine seems to be protected and supply safety for teenagers ages 6 months to six years, and it’s asking the Food and Drug Administration for emergency authorization.
Moderna says its low-dose pediatric vaccine seems to be protected and supply safety for teenagers ages 6 months to six years, and it’s asking the Food and Drug Administration for emergency authorization.